Search
Menu
Home
HTB
2024
January
January 2024
Contents
Editorial
HTB 2024: latest news online
Special reports
Uganda hate law blocks HIV research: join 300 leading researchers in sign-on protest
Uganda update: LGBT hate law challenged in the courts
Antiretrovirals
Five cases of viral failure on CAB-LA and RPV-LA injections
PK and drug interactions
Liverpool Drug Interactions: January update
FDA warns Amazon over supplements containing Viagra: hundreds of cases reported over ten years
Guidelines
BHIVA recommendations on measles in the UK
BHIVA update guidance on shingles vaccine
mpox (monkeypox)
Clinical efficacy of tecovirimat for treatment of mpox in people living with HIV
HIV prevention and transmission
PrEP douche achieves more protective drug levels than 2:1:1 oral dosing
Other news
Remarkable impact of DNDi over 20 years
HTB RSS
Early access
Semaglutide reduces alcohol and cigarette use in a randomised phase 2 study
12 February 2025
IAS public letter: Why HIV could be poised for a monumental comeback
6 February 2025
Lenacapavir for PrEP submitted to EMA for EU and global use
4 February 2025
New mpox vaccination sites open in the UK
3 February 2025
All early access reports
Current issues
February 2025
January 2025
December 2024
Back issues
Special report
Impact of US elections and executive orders on global health: waiver covers PEPFAR with restrictions
1 February 2025
More from HTB
Conference reports
Conference shortcuts
Articles by subject
PDFs
Subscribe
HTB homepage
Home
i-Base homepage
Donate